Results 81 to 90 of about 122,153 (397)

The potential role of cannabinoids in dermatology

Journal of dermatological treatment (Print), 2020
Cannabis is increasingly being used world-wide to treat a variety of dermatological conditions. Medicinal cannabis is currently legalized in Canada, 31 states in America and 19 countries in Europe.
T. Sheriff, Matthew J Lin, D. Dubin, H. Khorasani   +3 more
semanticscholar   +1 more source

Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies

Pain, 2018
This review examines evidence for the effectiveness of cannabinoids in chronic noncancer pain (CNCP) and addresses gaps in the literature by: considering differences in outcomes based on cannabinoid type and specific CNCP condition; including all study ...
E. Stockings, G. Campbell, W. Hall, S. Nielsen, Dino Zagic, R. Rahman, B. Murnion, M. Farrell, Megan Weier, L. Degenhardt   +9 more
semanticscholar   +1 more source

Cannabinoid Hyperemesis Syndrome [PDF]

, 2015
Legalization of marijuana use will increase the number of people who will become long-term users. A prior medical record review study in Australia, in 2004, identified 19 chronic marijuana users who entered the emergency department with recurrent ...
Heise, Lynn
core   +2 more sources

Cannabinoids, Blood–Brain Barrier, and Brain Disposition

Pharmaceutics, 2020
Potential therapeutic actions of the cannabinoids delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are based on their activity as analgesics, anti-emetics, anti-inflammatory agents, anti-seizure compounds.
F. Calapai, L. Cardia, E. E. Sorbara, M. Navarra, S. Gangemi, G. Calapai, C. Mannucci   +6 more
semanticscholar   +1 more source

How Cannabinol Is Utilized in Japan, a Country with Strict Cannabis Regulations—Its Purposes, Medical Effects, Adverse Events, and Dependence

Integrative Medicine Reports
Introduction: Cannabinol (CBN) was discovered in 1896, but its commercial use did not take off until recently, and there have been few studies on its use, safety, and efficacy.
Yuji Masataka, Futaba Umemura, Akihiko Nagamine, Naoko Miki, Yoshiyuki Akahoshi, Toshihiko Matsumoto, Ichiro Takumi   +6 more
doaj   +1 more source

Cannabinoids in Chronic Non-Cancer Pain: A Systematic Review and Meta-Analysis

Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders, 2020
Background: For patients with chronic, non-cancer pain, traditional pain-relieving medications include opioids, which have shown benefits but are associated with increased risks of addiction and adverse effects.
H. Johal, T. Devji, Yaping Chang, Jonathan Simone, C. Vannabouathong, M. Bhandari   +5 more
semanticscholar   +1 more source

Pricing Dynamics in the US Hemp Market: A Vertical Price Transmission Analysis of the Hemp Value Chain

Agribusiness, EarlyView.
ABSTRACT The US hemp market is a new and nascent industry that has been devoid of research for about half a century. This study examined the effects of exogenous shock on price at each phase of the value chain—Farm (hemp biomass), and its impact on prices at other phases of the value chain—Intermediary Processor (crude cannabidiol hemp) and Final ...
Solomon Odiase, Tyler Mark, Patalee Buddhika Appuhamilage   +2 more
wiley   +1 more source

Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study [PDF]

, 2008
<b>Objective</b>: To compare the analgesic efficacy and side effects of the synthetic cannabinoid nabilone with those of the weak opioid dihydrocodeine for chronic neuropathic pain.
Frank, B., Hughes, J., Kapur, D., Matthews, J.N.S., Serpell, M.G.   +4 more
core   +2 more sources

The Therapeutic Potential of Cannabis in Counteracting Oxidative Stress and Inflammation

Molecules, 2021
Significant growth of interest in cannabis (Cannabis sativa L.), especially its natural anti-inflammatory and antioxidative properties, has been observed recently.
Michał Graczyk, Agata Anna Lewandowska, Tomasz Dzierżanowski   +2 more
doaj   +1 more source

Associations Between Changes in Pain Sensitization and Disease Activity Following Disease‐Modifying Antirheumatic Drug Therapy in Established Rheumatoid Arthritis

Arthritis &Rheumatology, EarlyView.
Objective Abnormalities in pain regulatory mechanisms are common in patients with rheumatoid arthritis (RA). We investigated whether pain sensitization changes after treatment with a disease‐modifying antirheumatic drug (DMARD) and explored associations between changes in pain sensitization and disease activity.
Burcu Aydemir, Andrew C. Heisler, Lutfiyya N. Muhammad, Jing Song, Alyssa Wohlfahrt, Daniel J. Clauw, Wendy Marder, Marcy B. Bolster, Clifton O. Bingham, Tuhina Neogi, Yvonne C. Lee   +10 more
wiley   +1 more source